Follow the Third Harmonic Bio, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 14 August 2025 (J). Among the most active insiders: Conner Edward R.. Every trade is openly available.
23
Insider Decl.
n/a
Thresholds
€451,460
1 ops.
Buy Volume
€7m
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Third Harmonic Bio, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
28Σ signal
Buys €451,460€7m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Third Harmonic Bio, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias innovadoras para enfermedades inmunológicas. Cotiza en el NASDAQ bajo el ticker THRD.